No Detail Found!

An Overview on Diagnosis and Management of Neonatal Jaundice

Author(s)
Abdullah Dhafer Al Owaymir Faculty of Medicine, Bisah University,Bisah, KSA,
Rayan Mohammed A Aseeri Faculty of Medicine, Medical University of Warsaw, Warsaw, Poland
Mohammed Abdullah A Albariqi Faculty of Medicine, King Khalid University, Abha, KSA
Mona Saad Alalyani Faculty of Medicine, Princess Nourah Bint Abdulrahman University, Riyadh, KSA.
Jumanah Ahmed Ali Almansaf Faculty of Medicine, Almaarefa University, Riyadh, KSA
Almaha Bassam Khalil Albalwi Faculty of Medicine, Almaarefa University, Riyadh, KSA
Ruba Ali ALSalem Faculty of Medicine, King Saud University, Riyadh, KSA.
Khadijah Jadah Asiri Ahad Rufaidah General Hospital,Ahad Rufaidah, KSA,
Nadeyah Yossef Hamad Baeyti Faculty of Medicine, Jazan University, Jazan, KSA.
Kholoud Ali Alrobaie Faculty of Medicine, King Khalid University, Abha, KSA.
Abstract
Neonatal jaundice is a common clinical condition in the neonatal age, most frequently in the first week of life. It manifests due to different physiological and pathological phenomena related to the metabolism process of bilirubin. Data from Saudi Arabia identifies physiological jaundice as the most common cause in the region, followed by indirect hyperbilirubinemia, early onset jaundice, direct hyperbilirubinemia, and persistent hyperbilirubinemia jaundice. Early recognition and prompt treatment of the condition are crucial to evade serious complications and promote the neonate's health. The present study reviewed the literature searching for the etiology of neonatal jaundice, diagnosis, risk factors, and management of this disease. PubMed database was used for articles selection, and gathered papers had undergone a thorough review. Jaundice in newborns is rather common and can be caused by a variety of factors. Many doctors believe that infant jaundice is a minor condition, but it is a severe condition that can cause irreversible brain damage. Everyone in the field of neonatology should be aware of this. Furthermore, parent education is critical and to those in the field of neonatology.
Publication Details
Page(s) 99-102
Published Journal: Archives of Pharmacy Practice, Volume: 12, Issue: 2, Year: 2021

Request the full text from PASTIC

Keywords
Risk factors, Neonatal jaundice, Hyperbilirubinemia, Management
References
Bhutani VK,Zipursky A,Blencowe H,Khanna R,Sgro M,Ebbesen F .2013 .Neonatal hyperbilirubinemia and Rhesus disease of the newborn: incidence and impairment estimates for 2010 at regional and global levels. Pediatr Res, 10(1) : 86-100.
Infants Young .2008 .Clinical signs that predict severe illness in children under age 2 months: a multicentre study. Lancet (London, England), 6736(08) : 60106-3.
Burke BL,Robbins JM,Mac Bird T,Hobbs CA,Nesmith C,Tilford JM .2009 .Trends in hospitalizations for neonatal jaundice and kernicterus in the United States,. , 10(2) : 2915-32.
Alkhotani A,Eldin EE,Zaghloul A,Mujahid S .2014 .Evaluation of neonatal jaundice in the Makkah region. Sci Rep, 10(1) : 4802.
Mitra S,Rennie J .2017 .Neonatal jaundice: aetiology, diagnosis, and treatment. Br J Hosp Med (Lond), 78(12) : 699-704.
Boyd S. .2004 .Treatment of physiological and pathological neonatal jaundice. Nurs Times, 100(13) : 40-3.
Bratton S,Cantu RM,Stern M.,Island (FL): StatPearls Publishing M. .2021 .Breast Milk Jaundice. , : .
Mishra S,Agarwal R,Deorari AK,Paul VK. .2008 .Jaundice in the newborns. Indian J Pediatr, 10(2) : 157-63.
Pegoraro V,Urbinati D,Visser GH,Di Renzo GC,Zipursky A,Stotler BA .2020 .Hemolytic disease of the fetus and newborn due to Rh (D) incompatibility: A preventable disease that still produces significant morbidity and mortality in children. PLoS One, 10(7) : 1-11.
Akgül S,Korkmaz A,Yiğit S,Yurdakök M. .2013 .Neonatal hyperbilirubinemia due to ABO incompatibility: does blood group matter?. Turk J Pediatr, 55(5) : 506-9.
D'Silva S,Colah RB,Ghosh K,Mukherjee MB .2014 .Combined effects of the UGT1A1 and OATP2 gene polymorphisms as a major risk factor for unconjugated hyperbilirubinemia in Indian neonates. Gene, 05(1) : 18-22.
Kaplan M,Wong RJ,Stevenson DK,- Phosphate Dehydrogenase DK .2018 .. Neonatal Hyperbilirubinemia. Neonatology, 10(3) : 223-5.
Moiz B,Nasir A,Khan SA,Kherani SA,Qadir M.,Variant T .2012 .Neonatal hyperbilirubinemia in infants with G6PD c. BMC Pediatr, 10(1) : 1471.
.2004 .American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics, 10(1) : 297-316.
Maisels MJ,Bhutani VK,Bogen D,Newman TB,Stark AR,Watchko JF .2009 .Hyperbilirubinemia in the newborn infant > or =35 weeks' gestation: an update with clarifications. Pediatrics, 10(4) : 0329-8.
Bhatt DR,Kristensen-Cabrera AI,Lee HC,Weerasinghe S,Stevenson DK,Bhutani VK .2018 .Transcutaneous bilirubin meter use and practices surrounding jaundice in 150 California newborn intensive care units. J Perinatol, 10(11) : 1532-5.
Frank JE .2005 .Diagnosis and management of G6PD deficiency. Am Fam Physician, 72(7) : 1277-82.
Woodgate P,Jardine LA .2015 .Neonatal jaundice: phototherapy. BMJ Clin Evid, : .
Bujandric N,Grujic J .2016 .Exchange transfusion for severe neonatal hyperbilirubinemia: 17 years' experience from Vojvodina, Serbia. Indian J Hematol Blood Transfus an Off J Indian Soc Hematol Blood Transfus, 10(2) : 208-14.
Cortey A,Elzaabi M,Waegemans T,Roch B,Aujard Y .2014 .Efficacy and safety of intravenous immunoglobulins in the management of neonatal hyperbilirubinemia due to ABO incompatibility: a meta-analysis. Arch Pediatr, 02(9) : 976-83.
Kaabneh MA,Salama GS,Shakkoury AG,Al-Abdallah IM,Alshamari A,Halaseh RA .2015 .Phenobarbital and phototherapy combination enhances decline of total serum bilirubin and may decrease the need for blood exchange transfusion in newborns with isoimmune hemolytic disease. Clin Med Insights Pediatr, 10 : 67-72.
0

Citations

0

Downloads

10

Views